We are live on
!
Find out more
CFM
Catalyst Funds Management Portfolio holdings
AUM
$591M
1-Year Est. Return
71.09%
This Fund
S&P 500
This Quarter
Est. Return
+18.75%
1 Year Est. Return
+71.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$362M
AUM Growth
-$20.4M
(-5.3%)
Cap. Flow
-$61.6M
Cap. Flow
% of AUM
-17%
Top 10 Holdings %
Top 10 Hldgs %
19.16%
Holding
737
New
289
Increased
45
Reduced
94
Closed
308
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$9.8M |
| 2 |
Amphenol
APH
|
+$6.39M |
| 3 |
Applovin
APP
|
+$5.63M |
| 4 |
CRH
CRH
|
+$3.85M |
| 5 |
Insmed
INSM
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rio Tinto
RIO
|
+$11.7M |
| 2 |
Pfizer
PFE
|
+$7.17M |
| 3 |
NVIDIA
NVDA
|
+$7.15M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$7.02M |
| 5 |
Mastercard
MA
|
+$5.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Financials | 14.89% |
| 3 | Industrials | 12.22% |
| 4 | Materials | 11.64% |
| 5 | Healthcare | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONL
376
Orion Office REIT
ONL
$148M
| $47.9K | 0.01% |
+22,490
| New | +$42.9K |
|
|
SVC
377
Service Properties Trust
SVC
$1.1B
| $47.1K | 0.01% |
3,941
-13,999
| -78% | -$151K |
|
378
Black Diamond Therapeutics
BDTX
$101M
| $45.9K | 0.01% |
+18,500
| New | +$35.7K |
|
379
GoPro
GPRO
$116M
| $45.4K | 0.01% |
+60,000
| New | +$39K |
|
|
IRBT
380
DELISTED
iRobot
IRBT
| $44.4K | 0.01% |
+14,200
| New | +$39.3K |
|
381
Maravai LifeSciences
MRVI
$997M
| $44.2K | 0.01% |
+18,320
| New | +$38.5K |
|
382
TETRA Technologies
TTI
$1.23B
| $44K | 0.01% |
+13,100
| New | +$38.1K |
|
383
Vaalco Energy
EGY
$594M
| $42.5K | 0.01% |
+11,770
| New | +$40.9K |
|
384
Blink Charging
BLNK
$75.2M
| $42.2K | 0.01% |
+44,900
| New | +$35.9K |
|
385
Claros Mortgage Trust
CMTG
$306M
| $41.1K | 0.01% |
+14,405
| New | +$38.6K |
|
386
C4 Therapeutics
CCCC
$376M
| $40.5K | 0.01% |
+28,300
| New | +$41.2K |
|
387
Relay Therapeutics
RLAY
$4.02B
| $39.8K | 0.01% |
11,500
+1,400
| +14% | +$4.16K |
|
388
Rekor Systems
REKR
$83.8M
| $39.6K | 0.01% |
+34,100
| New | +$35.8K |
|
389
Pliant Therapeutics
PLRX
$67.5M
| $39.5K | 0.01% |
+34,015
| New | +$48.1K |
|
390
Kyverna Therapeutics
KYTX
$450M
| $36.8K | 0.01% |
+12,000
| New | +$29.7K |
|
391
Clean Energy Fuels
CLNE
$447M
| $36.7K | 0.01% |
+18,800
| New | +$32K |
|
392
Leslie's
LESL
$11.6M
| $36.3K | 0.01% |
+4,320
| New | +$56.9K |
|
393
ProKidney
PROK
$308M
| $36.2K | 0.01% |
+61,100
| New | +$47.6K |
|
394
Veru
VERU
$36.1M
| $35.7K | 0.01% |
+6,140
| New | +$34.5K |
|
395
Energy Vault
NRGV
$522M
| $35.7K | 0.01% |
+49,800
| New | +$40.2K |
|
396
Inovio Pharmaceuticals
INO
$79.8M
| $34.6K | 0.01% |
+17,000
| New | +$32.6K |
|
397
MacroGenics
MGNX
$235M
| $34.5K | 0.01% |
+28,500
| New | +$41.3K |
|
|
FLNA
398
Filana Therapeutics
FLNA
$43M
| $34K | 0.01% |
+18,800
| New | +$33.5K |
|
399
Cardlytics
CDLX
$21M
| $32.2K | 0.01% |
+1,960
| New | +$33.8K |
|
400
Cabaletta Bio
CABA
$439M
| $31.9K | 0.01% |
+21,000
| New | +$32.8K |
|
Similar funds
BBL
BA
DPRC
FL
MW
SM
LBIM
MPW
Catalyst Funds Management's Q2 2025 Portfolio in Review
As of Q2 2025, Catalyst Funds Management held 737 positions worth $362M, down 5.3% from $382M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Catalyst Funds Management withdrew a net $61.6M in Q2 2025, closing 308 positions and reducing 94 holdings. Its most notable exit was Pfizer, an estimated $7.17M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
Against the trend, Catalyst Funds Management opened a new position in VanEck Gold Miners ETF worth $10.3M.
- Catalyst Funds Management's largest Q2 2025 buy was VanEck Gold Miners ETF: 197,400 shares worth $10.3M.
- Catalyst Funds Management added most to Applovin in Q2 2025, an estimated $5.63M increase.
- Catalyst Funds Management's biggest Q2 2025 reduction was Rio Tinto, cutting an estimated $11.7M.
- Catalyst Funds Management fully exited Pfizer in Q2 2025, selling an estimated $7.17M.
- Catalyst Funds Management's ten largest holdings make up 19% of its $362M portfolio in Q2 2025.
- Catalyst Funds Management opened 289 new positions and closed 308 in Q2 2025.
- Catalyst Funds Management's portfolio value fell 5.3% quarter-over-quarter to $362M.
Based on Catalyst Funds Management's 13F filing for Q2 2025, filed 12 Aug 2025.